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Abstract
Background: Obesity is rising at an alarming rate globally. Different fermentable carbohydrates have been shown to reduce
obesity. The aim of the present study was to investigate if two different fermentable carbohydrates (inulin and b-glucan)
exert similar effects on body composition and central appetite regulation in high fat fed mice.
Methodology/Principal Findings: Thirty six C57BL/6 male mice were randomized and maintained for 8 weeks on a high fat
diet containing 0% (w/w) fermentable carbohydrate, 10% (w/w) inulin or 10% (w/w) b-glucan individually. Fecal and cecal
microbial changes were measured using fluorescent in situ hybridization, fecal metabolic profiling was obtained by proton
nuclear magnetic resonance (1H NMR), colonic short chain fatty acids were measured by gas chromatography, body
composition and hypothalamic neuronal activation were measured using magnetic resonance imaging (MRI) and
manganese enhanced MRI (MEMRI), respectively, PYY (peptide YY) concentration was determined by radioimmunoassay,
adipocyte cell size and number were also measured. Both inulin and b-glucan fed groups revealed significantly lower
cumulative body weight gain compared with high fat controls. Energy intake was significantly lower in b-glucan than inulin
fed mice, with the latter having the greatest effect on total adipose tissue content. Both groups also showed an increase in
the numbers of Bifidobacterium and Lactobacillus-Enterococcus in cecal contents as well as feces. b- glucan appeared to have
marked effects on suppressing MEMRI associated neuronal signals in the arcuate nucleus, ventromedial hypothalamus,
paraventricular nucleus, periventricular nucleus and the nucleus of the tractus solitarius, suggesting a satiated state.
Conclusions/Significance: Although both fermentable carbohydrates are protective against increased body weight gain,
the lower body fat content induced by inulin may be metabolically advantageous. b-glucan appears to suppress neuronal
activity in the hypothalamic appetite centers. Differential effects of fermentable carbohydrates open new possibilities for
nutritionally targeting appetite regulation and body composition.
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Introduction
The gut microbiota is emerging as an important environmental
factor associated with obesity and fat mass development [1].
Aberrant microflora profiles have been observed in both diet
induced animal models of obesity [2] as well as in obese humans
compared with lean controls [3]. Moreover, obese individuals on
either a fat-restricted or carbohydrate-restricted low calorie diet
have been shown to alter the gut bacteria compositions toward an
increase of bacteroides and a reduction of firmicutes [3].
It is known that fermentable carbohydrates like inulin,
oligofructose (fructans) and b-glucan undergo bacterial fermenta-
tion in the colon [4,5]. Fermentable carbohydrates such as
partially hydrolyzed guar gum and fructo-oligosaccharides have
been shown to modulate the intestinal microbiota by increasing
the proportions of bifidobacteria and lactobacilli in humans [6].
Supplementation of dietary fructans has also been shown to
increase the level of anorectic gastrointestinal hormones such as
glucagon like peptide-1 (GLP-1) and peptide YY (PYY) thereby
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reducing body weight gain in experimental animals [7]. The
addition of oligofructose into the diet of obese adults for three
weeks was shown to reduce body weight, suppress plasma ghrelin
and enhance PYY levels [8]. Evidence shows that barley b-glucan
also mediates a satiety effect through increased PYY and a
reduction in ghrelin levels [9]. Moreover, the end products of
bacterial fermentation, short chain fatty acids have been shown to
regulate expression of the gut hormones implicated in satiety [10].
Previously we have shown that the increase in satiety as a result of
resistant starch supplementation correlates with decrease in
neuronal activation in the hypothalamic appetite centers using
manganese enhanced magnetic resonance imaging (MEMRI)
[11].
In the present study, we bring together a number of cutting-
edge techniques to evaluate the efficacy of two different
fermentable carbohydrates (b-glucan and oligofructose enriched
inulin) in delaying the progression of obesity under high fat dietary
conditions. We hypothesize that such carbohydrates may have a
similar impact on body weight reduction but the underlying
mechanisms by which they reduce weight gain may differ.
Materials and Methods
Animals and Treatments
All animal procedures were performed in accordance with the
UK Animals Scientific Procedures Act (1986). Thirty six male
C57BL/6 mice (6–8 weeks old, Charles River, UK) were single
housed under controlled temperature (21–23uC) and light
conditions (12 h light-dark cycle; lights on at 07:00 h). Animals
were randomized and assigned to three different groups (n = 12):
High fat diet (HFD, with corn starch) as high fat control (HFD-C),
HFD + oligofructose enriched inulin (SynergyTM) (HFD-I) and
HFD + b-glucan (GlucagelTM) (HFD-BG). While SynergyTM is a
fructan based preparation containing both long and short chain
fructooligosaccharides, GlucagelTM is a highly rich (,80%) barley
derived b-glucan preparation (DKSH, London, UK). Both
Synergy and GlucagelTM were mixed with the HFD individually
in the ratio of 1:9, the detailed composition of diets is given in the
Table S1. The three diets were isocaloric, each contained the same
total energy of 4.6 kcal/g, with 41.8% energy from fat. HFD diet
was made isocaloric by the addition of cellulose. The diets were fed
ad libitum for 8 weeks to respective group of animals. Body weights
and food intake were measured three times per week. A schematic
diagram outlining the study design is shown in Fig. 1.
Fluorescent in situ hybridization (FISH)
The protocol was followed as previously described by Martin-
Pelaez et al. [12] See method S1 for details. The probes used were
Lab158 [13], Bif164 [14], Erec482 [15] and Mib663 [16] to
enumerate Lactobacillus-Enterococcus, bifidobacteria, Eubacterium rec-
tale-Clostridium coccoides and mouse intestinal bacteria belonging to
Bacteroides subgroup in the phylum Cytophaga-Flavobacter-Bacteroides,
respectively. Total cell counts were obtained with DAPI (49,6-
diamidino-2-phenylindole dihydrochloride) staining.
1H nuclear magnetic resonance (NMR) spectroscopy
Fecal samples were prepared and analyzed by 1H NMR using
method adapted from Saric et al. [17]. See method S1 for details.
Gas chromatography
Short chain fatty acids (SCFA) in the colonic contents were
determined by gas chromatography. The method used was
adapted from Richardson et al [18]. See method S1 for details.
Magnetic resonance studies
A combination of magnetic resonance imaging and spectrosco-
py (MRI/S) techniques explained below were carried out to
determine body composition in terms of total body fat content and
distribution, and ectopic lipid levels in liver and muscle tissue. We
also used MEMRI to assess the impact of fermentable carbohy-
drates on appetite centres in the hypothalamus.
Whole body 1H MRS. Whole body 1H MRS was performed
to determine the whole body adiposity. The mice were fasted for
16 h and anesthetized with 1–2% isoflourane-oxygen mix which
was maintained throughout the scan. The animals were scanned
on a 4.7 Tesla Varian INOVA imaging system (Varian Inc, USA)
using a pulse sequence with the following parameters: repetition
time (TR) = 10 s, pulse angle = 45u and averages = 4. The spectra
obtained were analyzed and body adiposity was calculated as
previously described [11].
Whole body MRI. Whole body MRI was carried out to
determine the amount of internal (epididymal and mesenteric fat)
and total subcutaneous depots. Consecutive 2 mm thick slices
were acquired using a spin-echo sequence with the following
parameters: TR=2.2 s, echo time (TE) = 20 ms, matrix
size = 2566192, field of view (FOV) = 45645 mm and averag-
es = 2. The slices/images were then subjected to segmentation
analysis (SliceOmaticTM, TomovisionH, Canada) by an observer
blinded to the experimental groups to obtain volumes and the
masses of the different adipose tissue depots were calculated.
Localized 1H MRS. Localized 1H MRS was performed to
assess the lipid content in the liver and muscle. The intrahepa-
tocellular and intramyocellular lipid content was assessed by
placing a voxel of 26262 mm3 on a selected slice of the liver and
muscle in the MR images. A PRESS sequence with the following
parameters, TR=10 s, TE= 9 ms and averages = 64, was applied
on the voxel to obtain the spectra and relative percentage of lipid
was determined by integration of the lipid peak [11].
Manganese enhanced MRI (MEMRI). MEMRI was
performed to determine the neuronal activation in selected
appetite centers of brain using 9.4 Tesla Varian INOVA imaging
system (Varian Inc, USA) as described earlier. The mice for
MEMRI were selected by the average body weight of each group
and they had free access to food and water before the scan. Mice
were anesthetized with 1–2% isoflourane-oxygen mix which was
maintained throughout the scan. A fast spin-echo multi-slice
sequence was applied with the following parameters:
TR=600 ms, TE= 10 ms, matrix size = 1926192,
FOV=25625 mm and average = 1 acquiring 4660.4 mm thick
slices [19]. An array of 66 acquisitions was set up so that the 46
slices were acquired 66 times throughout the infusion. Maximum
three scans were performed per day during the day light time and
each scan lasted for 2 hr. Normalized percentage enhancement
(NPE) in signal intensity was calculated in the hypothalamic
appetite centers like arcuate nucleus (ARC), ventromedial
hypothalamus (VMH), paraventricular nucleus (PVN), periven-
tricular nucleus (PE), and the brainstem region like nucleus of
tractus solitarius (NTS) [20].
Adipocyte cell size and number
Adipocyte cell size and number were determined as reported
earlier [21–23]. Briefly, white adipose tissue (epididymal depot)
was collected and finely minced in Dulbecco’s modified Eagle
medium (DMEM) supplemented with 4% (w/v) Bovine serum
albumin (BSA) and collagenase (1 mg/0.5 g tissue). The tissue
suspension was incubated in a shaking water bath set at
140 cycles/min for 45 min at 37uC. After the tissue was
completely digested, the suspension was filtered through a
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polypropylene mesh (400 mm) and washed twice using DMEM
containing 4% (w/v) BSA and 1 mg/40 ml trypsin inhibitor. An
aliquot (10 ml) of adipocytes was collected, diluted with trypan blue
in 1:1 ratio and a sample of the cells were counted in a
haemocytometer. Images were taken of different sample regions of
the grid on the haemocytometer for further analysis. Cell number
and size (diameter, mm) was calculated from images using software
CellProfiler (Masachusetts, USA) setting an appropriate threshold
to exclude any cell debris.
Colonic PYY extraction and radioimmunoassay
PYY was extracted from the colons by boiling for 15 minutes in
0.5 M acetic acid (10 ml/g wet weight of colon) as described
previously [24]. Extracts were stored at 220uC until assayed.
Colonic PYY and PYY3–36 immunoreactivity in serum was
measured using radioimmunoassay [25].
Statistical Analysis
All data was checked for normality, and results expressed as
means 6 standard errors (SE), unless otherwise stated. In the case
of the gut microbiota, the data is presented as median and 95%
confidence intervals. Unless otherwise stated, data was analyzed
using two way ANOVA with post-hoc bonferroni correction. PYY
and MRI results were analyzed by one way ANOVA using
software GraphPad prism5. MEMRI timecourse data was
analyzed using GEE with post-hoc Mann Whitney analysis [26].
For the acquired 1H NMR fecal spectra data, the spectra were
initially referenced to sodium 3-trimethylsilyl [2,2,3,3-2H4] propi-
onate, TSP (d 0.0), corrected for baseline distortions and phased
using an in-house routine written in MatlabH 7.3.0 (MathWorks,
Natick, MA) and each spectrum was collected into the 0.005 ppm
spectral region [27]. Analysis of the spectral data was performed
initially using principal component analysis (PCA). Following
PCA, pair wise orthogonal projection to latent structure discrim-
inating analysis (OPLS-DA) models between different types of diet
and at different time points were calculated separately using one
predictive and one orthogonal component. Due to the small
number of samples in this report, separation within the model was
considered significant when p#0.01. The computed regression
coefficient plots [28] were used to identify the differential
contribution of spectral regions in discrimination between class
separations. Metabolites which were highly correlated to the class
separations were assigned using published literature, statistical
total correlation spectroscopy [29] and public databases.
Results
Body weight, food intake, tissue weights and adiposity
data
Both oligofructose enriched inulin (HFD-I) and b-glucan (HFD-
BG) fed mice (n = 12 per group) displayed significantly lower
(p,0.05) body weights at weeks 7 and 8 compared with high fat
control mice (HFD-C). Cumulative body weight gain was
significantly lower (p,0.05) in HFD-I and HFD-BG compared
with HFD-C from week 3 onwards and this was maintained until
the end of the dietary intervention giving a net reduction of 30%
and 37%, respectively (Fig. 2a).
No difference in cumulative food intake was observed between
HFD-C and HFD-I groups (Fig. 2b) despite a significantly lower
cumulative body weight gain in the HFD-I group. The HFD-BG
group showed a significantly lower cumulative food intake from
week 4 as compared to HFD-C (p,0.001) and from week 6 as
compared to HFD-I (p,0.05). Despite a significantly lower
cumulative food intake in HFD-BG mice, no significant difference
in cumulative body weight gain was observed between HFD-BG
and HFD-I groups.
Figure 1. Flowchart showing the study design.
doi:10.1371/journal.pone.0043263.g001
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Epididymal fat mass was significantly lower (p,0.05) in HFD-I,
while cecal weight (along with contents) was significantly higher
(p,0.001) in both HFD-I and HFD-BG, compared with HFD-C
(n = 6 per group, Table 1). The cecal weight of HFD-BG mice was
significantly lower than that of HFD-I mice (p,0.01). Liver and
colonic weights did not differ significantly.
Body composition and adipocyte data
Whole body adiposity measured by 1H MRS (n= 6 per group)
at week 8 showed a stepwise increase with HFD-I the lowest,
followed by HFD-BG than HDF-C group. HFD-I (8.9561.66%)
was significantly lower (p,0.05) compared with both the HFD-BG
(12.1761.92%) and HDF-C (18.0362.72%) groups (Table 1).
There were no significant differences in internal and subcutaneous
fat levels, however, a trend towards a lower internal and
subcutaneous fat was observed in HFD-I and HFD-BG compared
with HFD-C group. There were no significant differences
observed in either liver or muscle lipid content between any of
the three groups.
Adipocyte size was significantly lower (p,0.05) in the HFD-I
(72.9568.72 mm) compared to either the HFD-BG
(111.1964.03 mm) or HFD-C (122.25610.2 mm), however, there
was no significant change in adipocyte number between the
different groups (Table 1).
Gut microflora composition and SCFAs
Fluorescence in situ hybridization (FISH) was carried out in both
fecal pellets (collected at weeks 0, 4 and 8) and cecal contents at
week 8 (when the mice were culled). A significant modulation of
bacterial populations was observed in both the cecal and fecal
contents (n = 6 per group, Fig. 3). Bacterial groups, Lactobacillus-
Enterococcus and Bifidobacterium hybridized with probes Lab156 and
Bif164, respectively, showed a significant increase in both HFD-I
(p,0.001) and HFD-BG (p,0.01) compared to HFD-C in cecal
contents post dietary intervention at week 8. HFD-I and HFD-BG
fed mice also exhibited a significant increase in total bacterial
(p,0.05), MIB (p,0.05) and EREC counts (p,0.01) compared to
HFD-C (Fig. 3a).
Baseline fecal microbial contents were similar for mice fed with
different diets (Fig. 3b–f). No significant changes in the fecal
microbial contents were observed in HFD-C group over the 8
weeks dietary intervention. However, a non-significant reduction
in the total bacteria and EREC was observed at week 8 in HFD-C
group. The intake of fermentable carbohydrates resulted in a
Figure 2. The effect of inulin and b-glucan supplementation over the 8-week dietary interventional period (a) weekly cumulative
body weight gain, n=12 per group (b) weekly cumulative food intake over the 8 week dietary intervention period, n=12 per
group. * =p,0.05, ** =p,0.01, ***=p,0.001. Key: HFD-C, high fat diet control; HFD-I, high fat diet+inulin; HFD-BG, high fat diet+b-glucan.
doi:10.1371/journal.pone.0043263.g002
Table 1. Effect of inulin and b-glucan supplementation on
adiposity parameters and tissue weights in high fat fed mice
(n = 6).
HFD-C HFD-I HFD-BG
Epididymal adipose tissue (g) 1.1460.16 0.5960.10* 0.7760.10
Whole body adiposity (%) 18.0362.72 8.9561.66* 12.1761.92
Liver lipid content (%) 6.3061.62 6.0261.97 6.0261.36
Muscle lipid content (%) 0.9660.149 0.7260.05 1.2960.57
Internal fat (g) 2.1760.46 1.2360.17 1.4960.27
Subcutaneous fat (g) 3.4060.53 2.0860.13 2.4460.28
Adipocyte size ( mm) 122.25610.2 72.9568.72**,# 111.1964.03
Adipocyte number (6107) 1.43E+08 1.31E+08 1.86E+08
Liver size (g) 1.4360.13 1.2360.15 1.4060.06
Caecum (with contents, g) 0.2160.01 0.6960.05***,## 0.4960.03***
Caecum (without contents, g) 0.0660.01 0.2160.01***,## 0.1460.01***
Colon (g) 0.1360.01 0.1960.02 0.1460.02
Superscipt (*) shows the significant difference between HFD-I or HFD-BG vs.
HFD-C.
* = P,0.05,
** = P,0.01,
*** = P,0.001.
Superscipt (#) shows the significant difference between HFD-I vs. HFD-BG.
#= P,0.05,
##= P,0.01.
doi:10.1371/journal.pone.0043263.t001
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significant increase (p,0.001) in the numbers of total bifidobac-
teria and lactobacilli as compared to week 0, showing a similar
pattern of microbial modulation as observed in cecal contents.
Other bacterial groups, MIB bacteroides, residing within Cyto-
phaga-Flavobacter-Bacteroides phylum (p,0.001) and EREC, Eubac-
terium rectale-Clostridium coccoides numbers (p,0.01) also increased in
HFD-I as compared to HFD-C group.
Total level of SCFAs (acetate, propionate and butyrate) (n = 6
per group) were significantly higher in the HFD-BG group
compared with the HFD-I group, which in turn was higher than
the HFD-C group (HFD-BG: 34.462.5 mmol/mg; HFD-I:
27.862.1 mmol/mg; HFD-C: 17.764.1 mmol/mg, p,0.05) in
the colonic contents. Acetate and propionate levels were signifi-
cantly increased in HFD-BG and HFD-I compared with HFD-C
(Acetate; HFD-BG: 30.262.4 mmol/mg; HFD-I:
25.163.1 mmol/mg; HFD-C: 16.763.1 mmol/mg, p,0.05:
Propionate; HFD-BG: 3.061.2 mmol/mg; HFD-I:
2.060.9 mmol/mg; HFD-C: 0.660.3 mmol/mg, p,0.05). How-
ever, there was no significant difference observed in the butyrate
levels among the three groups (HFD-BG: 1.160.3 mmol/mg;
HFD-I: 0.760.2 mmol/mg; HFD-C: 0.460.1 mmol/mg,
p = 0.260).
MEMRI
MEMRI was carried out at the end of the 8 weeks dietary
intervention to measure neuronal activation in the appetite centers
of brain (n = 6 per group) (Fig. 4a–e). Significantly lower signal
intensities were observed in the ARC (p,0.05), VMH (p,0.001),
PVN (p,0.01), PE (p,0.001) and NTS (p,0.05) in HFD-BG fed
mice when compared to HFD-C group of mice. No significant
difference was found between HFD-C and HFD-I groups for
ARC, VMH, PVN and PE except the MEMRI pattern in NTS
which was significantly (p,0.05) lower in HFD-I fed mice. HFD-I
group generally showed higher signal intensities for the neuronal
activation in the appetite centers of the brain when compared to
the HFD-BG group. However, these changes were not significant
except for the MEMRI pattern in PE (p,0.01) (Fig. 4d).
Serum and colonic PYY content
There was no statistical difference observed in the serum (HFG-
BG: 0.1360.016 pmol/mL; HFD-I: 0.0960.008 pmol/mL; and
HFD-C: 0.1060.012 pmol/mL) and colonic tissue (HFG-BG:
19.961.6 pmol/mL; HFD-I: 22.865.3 pmol/mL; and HFD-C:
27.363.7 pmol/mL) concentrations of PYY.
Figure 3. The effect of inulin and b-glucan supplementation on cecal and fecal microbial contents over the 8-week dietary
interventional period (a) cecal microflora groups, n=6 per group (b) fecal total bacteria microflora at week 0, 4 and 8, n=6 per
group: (c) fecal mouse intestinal bacteria, (d) fecal Eubacterium rectal-Clostridium coccoides; (e) fecal Lactobacilli; and (f) fecal
Bifidobacteria. * =p,0.05, ** =p,0.01, *** =p,0.001. Key: HFD-C, high fat diet control; HFD-I, high fat diet+inulin; HFD-BG, high fat diet+b-
glucan.
doi:10.1371/journal.pone.0043263.g003
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NMR results
Fecal pellets collected at week 0, 4 and 8 were measured by 1H
NMR spectroscopy to obtain the spectral profiles and to analyze
prominent signals from metabolites (Figure S1). The global fecal
metabolite composition was significantly different in HFD-C from
mice fed either of the fermentable carbohydrates as determined by
principal components analysis (PCA), whereby two clusters were
observed in the scores plots relating to HFD-I and HFD-BG versus
HFD-C (Figure S2). The variation in the first two principal
components was dominated by consumption of fermentable
carbohydrate, such that no time trajectory patterns were observed.
Statistics for various pairwise OPLS-DA comparisons between
different fermentable carbohydrates are shown in Table S2. No
significant difference was observed for the comparison between
HFD-BG and HFD-I. However, clear differentiation of both
HFD-I and HFD-BG from the HFD-C group was confirmed by
orthogonal partial least squares discriminant analysis (OPLS-DA)
which gave Q2 Yhat values of 94.1% and 85.6% respectively for
HFD-I and HFD-BG at week 8 (Table S2), indicating that the
separations between these models are highly robust.
The regression coefficient plots indicated that lactate; citric acid
cycle intermediates (succinate, fumarate); amino acids (lysine,
alanine, glutamate, aspartate, and glycine); and aromatic com-
pounds (uracil, tyrosine and phenylalanine) were the dominant
metabolites in the feces of HFD-I and HFD-BG groups. Fecal
glucose level was characteristic of HFD-BG mice at week 8. The
Figure 4. Representative baseline (pre-contrast) MRI images of the mouse brain showing assignment of regions of interest (ROIs) in
various brain areas from which signal intensities (SI) were obtained. Time course of changes in SI (as a percentage of baseline) before and at
various times after IV manganese chloride infusion in the (a) ARC, (b) VMH (c) PVN (d) PE (e) NTS. Data are presented as means of four consecutive
image acquisitions6SEM. * = p,0.05, ** = p,0.01, *** = p,0.001 Key: ARC, arcuate nucleus; VMH, ventromedial hypothalamic nucleus; PVN,
paraventricular hypothalamic nucleus; PE, periventricular nucleus; NTS, nucleus of solitaries tractus; HFD-C, high fat diet control; HFD-I, high fat
diet+inulin; HFD-BG, high fat diet+b-glucan.
doi:10.1371/journal.pone.0043263.g004
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integration of 1CH glucose signal at d5.230–5.262 showed that
glucose was approximately three times greater in the feces from
HFD-BG mice compared to HFD-I and HFD-C groups. Bile
acids; possibly amine related compounds (characterized by the
broad singlets in d8.5, 8.85 and 8.95); and an unknown metabolite
at d1.17 were highly correlated to HFD-C mice (shown for week 8
in Fig. 5).
Discussion
In the present study, we confirm the finding of others that both
b-glucan [30] and inulin [7,31] attenuate weight gain in high fat
fed mice. Although both groups that were fed fermentable
carbohydrates displayed a similar significant decrease in cumula-
tive body weight gain compared to the high fat control group, the
significant decline in cumulative food intake occurred earlier
(HFD-BG, week 4 vs. HFD-I, week 6), and was significantly
greater in the HFD-BG compared with HFD-I group. However, a
significantly greater reduction in body adiposity was observed in
the HFD-I group as compared to HFD-BG and HFD-C groups.
Considering both the HFD-BG and HFD-I have the similar end
body weight reduction, it would suggest that energy intake alone
does not account for weight loss and change in body composition
in the HFD-I group. Consistent with the decrease in body weight
HFD-BG and HFD-I had lower body fat that HFD-C with HFD-I
significantly lower than the other two groups. Although not
significantly different between HFD-BG and HFD-I, a trend
towards a lower internal fat than HFD-C was observed, with
HFD-I having a smaller epididymal fat pad. It is possible that
inulin may have a preferential effect on adipose tissue. The
mechanism by which inulin displays a greater effect on adipose
tissue is unclear, although we and others have reported impact of
inulin on body fat content previously [19]. There is evidence that
inulin may affect fatty acid oxidation [32].
A 1H NMR spectroscopy-based metabolomic approach was
used to characterize the metabolic profiles of the feces. Here, no
significant difference was observed between the 1H NMR spectra
of the HFD-I and HFD-BG groups. However, compared to HFD-
C, the effects of the b-glucan and inulin on body weight reduction
were coupled with the increased excretion of amino acids, citric
acid cycle intermediates and lactate. This suggests enhanced fecal
energy loss, in both groups through these energy related
compounds. It also reflects reduced utilization of these energy
related compounds that may have led to reduced body weight gain
in fermentable carbohydrates fed groups under high fat dietary
conditions. The HFD-BG group had increased fecal excretion of
Figure 5. Multivariate statistical analysis of the fecal 1H NMR spectra. OPLS-DA cross validated scores plots for mice fed with (a) HFD-C and
HDF-BG; and (b) HFD-C and HFD-I. The corresponding coefficient plots indicated fecal metabolic differences for (c) HFD-C and HFD-BG; and (d) HFD-C
and HFD-I. Insets show an expansion of the aromatic region. HFD-C, high fat diet control; HFD-I, high fat diet+inulin; HFD-BG, high fat diet+b-glucan.
1, Bile acids; 2, Butyrate; 3, Isoleucine, leucine and valine; 4, Propionate (tentative); 5, Unknown at d 1.17 (doublets) ; 6, Lactate; 7, Alanine; 8, Acetate; 9
Glutamate (tentative); 10, Succinate; 11, Aspartate; 12, Citrate; 13, Lysine; 14, Glycine; 15, Glucose and amino acids; 16, Glucose; 17, Uracil; 18,
Fumarate; 19, Thyrosine; 20, Phenylalanine; 21, Histidine; 22, Unknown at d7.84 (doublets); 23, Unknown at d8.02 (doublets); 24, Unknown at d8.20
(doublets); 25, Amine related compounds.
doi:10.1371/journal.pone.0043263.g005
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glucose at week 8, which may indicate incomplete fermentation of
b-glucan. This may be an indication of an additional loss of energy
in the HFD-BG.
Next we investigated if the differences in energy intake between
the HFD-BG and HFD-I could be ascribed to changes in the gut
microbiota. The high fat control diet had little effect on fecal total
microbiota temporally, as measured by FISH at repeated intervals,
over the 8 weeks dietary intervention. However, supplementation of
both fermentable carbohydrates resulted in modulation of gut
microbiota leading to an increase in total Lactobacillus-Enterococcus
and Bifidobacterium both in feces and cecal contents over the 8 weeks
dietary intervention. This suggests similar prebiotic efficacy of both
fermentable carbohydrates in modulating the microbiota and
supports previous reports on the prebiotic potential of oligofructose
enriched inulin [4] and b-glucan [5]. Our results also support
previous observations that increased intestinal bifidobacteria relates
to reduced body weight gain and food intake [33]. Thus, there is the
potential for utilizing fermentable carbohydrates to modulate the
gut microbiota to ameliorate the detrimental effects induced by high
fat diets, which is supported by our current data, but this does not
fully account for the difference in energy intake.
Recent evidence has implicated the ratio of firmicutes:bacter-
oidetes as one of the environmental factors regulating energy
homeostasis. It appears that obese mice and humans possess more
bacterial groups belonging to firmicutes, which possess fermenta-
tion ability to extract energy from otherwise indigestible carbohy-
drates [2]. The energy derived from these indigestible carbohy-
drates in the form of SCFAs contributes to total energy in adults
[34] and to the obese phenotype. However, in the present study,
we observed higher proportions of lactobacilli belonging to
firmicutes as well as enhanced cecal bacteroides number, (as
evident from increased cecal MIB counts) coupled with higher
total colonic SCFA content in HFD-I and HFD-BG compared
with HFD-C, accompanied by a reduction in body weight. Using
high throughput analysis, Everard et al also demonstrated increase
in bifidobacteria and bacteroidetes with oligofructose supplemen-
tation in ob/ob mice. However, they reported decrease in
firmicutes coupled with modulation of actinobacteria and
proteobacteria populations [35]. Our previous work has demon-
strated that fermentable carbohydrates can effect hypothalamic
neuronal activation [19]. MEMRI is an imaging technique which
gives a measure of neuronal activation in vivo. Manganese ions
(Mn2+) enter into the excitable neuronal cells in the brain
producing contrast in the MRI images. The appetite centers are
located in the hypothalamus, that include the arcuate nucleus
which is comprised of neurons expressing orexigenic (neuropeptide
Y, agouti related peptide) and anorexigenic (proopiomelanocortin,
melanocyte stimulating hormone) peptides, which project into
other areas like VMH and PVN. Brainstem is another region
which acts as the receiver of vagal afferent signals from all along
the gastro intestinal tract and all the signals are transmitted to
hypothalamus [19,20]. We demonstrated a significant decrease in
the signal intensity due to manganese uptake, measured in the
ARC, VMH, PVN in the HFD-BG group. These patterns of
activation are similar to those previously reported with acute
infusion of anorectic gut hormones such as PYY and GLP-1
[36,37].The results, therefore, reflect a satiated state in b-glucan
fed mice, which is paralleled by the significantly lower and earlier
decline in the cumulative food intake. A similar decrease in VMH
and PVN nuclei has earlier been reported in resistant starch fed
mice [11]. It has been shown that a decrease in these basal levels of
neural activity is an effect of a satiated state, in a study comparing
fed and fasted neural activity in these hypothalamic nuclei [26].
Therefore, despite the fact that there are populations of neurons
present in the arcuate nucleus, for example, which have opposing
effects on appetite, the overall effect detected with MEMRI links a
higher activation with a fasted state [26].
We expected a similar reduction in the signal intensity of HFD-I
group, but instead MEMRI patterns resembled those of the HFD-
C, except for in the NTS. NTS is located in brainstem, the
significantly lower MEMRI signal in NTS in inulin fed animals
was not coupled with parallel lower signal intensity in the
hypothalamic appetite regions. This is a surprising finding, raising
the possibility of different mechanisms of action behind the anti-
obesity potential of these two different fermentable carbohydrates.
The peripheral changes produced due to inulin supplementation
in diet were reflected in brainstem but it did not produce satiated
state in mice as compared to HFD-BG. A further explanation may
lie in the differences in viscosity and solubility of two different
fermentable carbohydrates. Whereas inulin is highly soluble, beta-
glucan forms a viscous solution in water. It has been reported that
viscosity better explains reduction in energy intake as compared to
solubility and fermentability of fibers [38].
Increased expression of the anorectic gut hormones GLP-1 and
PYY mRNA in the colon and increased portal GLP-1 concentra-
tions in fermentable carbohydrate fed rodents have been reported
previously [7,39,40]. The effect was attributed to the increased level
of SCFAs in these studies. However, despite higher concentration of
SCFA in the feces of both the inulin and b-glucan groups, we found
no significant differences for PYY levels as well as colonic expression
between the groups, due to limited tissue and plasma we were
unable to measure GLP-1. We suggest that our observations link
with a potential role of SCFA impacting on peripheral metabolism
rather than colonic anorectic gut hormones.
SCFA have been shown to have direct metabolic effects on
adipocytes through the SCFA receptor FFAR2 (Free Fatty Acid
Receptor 2) causing a reduction of FFA output in adipocytes [41].
The SCFA receptor FFAR3 (Free Fatty Acid Receptor 3) has been
shown to be expressed in sympathetic nervous system ganglia [42]
and its stimulation increases energy expenditure. In the present
study, total SCFA content was highest in HFD-BG followed by
HFD-I as compared to HFD-C. Therefore, it is possible to speculate
that different levels and patterns of SCFAs produced may cause
differential activation of FFAR2 and FFAR3 in adipose tissue and
appetite centers in brain, respectively, leading to the different effects
of inulin and b-glucan observed in the present study.
In conclusion, this study supports the work of others and
demonstrates that dietary supplementation of inulin or b-glucan
limits weight gain in high-fat fed animals, however, it highlights
the multiple mechanisms involved to explain these observations. b-
glucan supplementation appears to have a greater impact on
energy intake than inulin despite both groups ending at the similar
weight reduction. Supplementation of both compounds caused
energy loss in the feces, a positive change in the microbiota, with
no change in colonic PYY content. Inulin appears to have a
greater effect on limiting total adipose tissue content and adipocyte
size, whereas b-glucan affected appetite regulation by suppressing
neuronal activation in the hypothalamic nuclei implicated in the
appetite high fat control. The study highlighted the multi-factorial
nature of these molecules on energy homeostasis. Understanding
of the different mechanisms involved may open up new strategies
for nutritionally targeting obesity.
Supporting Information
Method S1 Supplementary information for detailed
methods used.
(DOCX)
Fermentable Carbohydrates and Appetite Regulation
PLOS ONE | www.plosone.org 8 August 2012 | Volume 7 | Issue 8 | e43263
Table S1 Composition of diets.
(DOCX)
Table S2 Pair wise OPLS-DA models assessed by
Q2Yhat and the significance of model based on 500
times random permutation of Y matrix.
(DOCX)
Figure S1 Median fecal 1H NMR spectra of mice (a)
HFD-C (b) HFD-BG and (c) HFD-I.
(TIF)
Figure S2 PCA scores plot of fecal metabolite profiles
showing clear clustering patterns for HFD-C, HFD-BG
and HFD-I groups of mice.
(TIF)
Author Contributions
Conceived and designed the experiments: TA RLL JA GRG KMT RKS
JRS ERD MLS ELT EH JDB GF. Performed the experiments: TA RLL
JA KMT RKS JRS ERD MLS ELT. Analyzed the data: TA RLL JA
GRG KMT RKS JRS ERD MLS ELT EH JDB GF. Contributed
reagents/materials/analysis tools: GRG EH JDB GF. Wrote the paper: TA
RLL JA GRG KMT RKS JRS ERD MLS ELT EH JDB GF.
References
1. Backhed F, Ding H, Wang T, Hooper LV, Koh GY, et al. (2004) The gut
microbiota as an environmental factor that regulates fat storage. Proc Natl Acad
Sci U S A 101: 15718–15723.
2. Ley RE, Backhed F, Turnbaugh P, Lozupone CA, Knight RD, et al. (2005)
Obesity alters gut microbial ecology. Proc Natl Acad Sci U S A 102: 11070–
11075.
3. Ley RE, Turnbaugh PJ, Klein S, Gordon JI (2006) Microbial ecology: human
gut microbes associated with obesity. Nature 444: 1022–1023.
4. Kleessen B, Hartmann L, Blaut M (2001) Oligofructose and long-chain inulin:
influence on the gut microbial ecology of rats associated with a human faecal
flora. Br J Nutr 86: 291–300.
5. Snart J, Bibiloni R, Grayson T, Lay C, Zhang H, et al. (2006) Supplementation
of the diet with high-viscosity beta-glucan results in enrichment for lactobacilli in
the rat cecum. Appl Environ Microbiol 72: 1925–1931.
6. Tuohy KM, Kolida S, Lustenberger AM, Gibson GR (2001) The prebiotic
effects of biscuits containing partially hydrolysed guar gum and fructo-
oligosaccharides–a human volunteer study. Br J Nutr 86: 341–348.
7. Cani PD, Neyrinck AM, Maton N, Delzenne NM (2005) Oligofructose promotes
satiety in rats fed a high-fat diet: involvement of glucagon-like Peptide-1. Obes
Res 13: 1000–1007.
8. Parnell JA, Reimer RA (2009) Weight loss during oligofructose supplementation
is associated with decreased ghrelin and increased peptide YY in overweight and
obese adults. Am J Clin Nutr 89: 1751–1759.
9. Vitaglione P, Lumaga RB, Stanzione A, Scalfi L, Fogliano V (2009) beta-
Glucan-enriched bread reduces energy intake and modifies plasma ghrelin and
peptide YY concentrations in the short term. Appetite 53: 338–344.
10. Kaji I, Karaki SI, Tanaka R, Kuwahara A (2010) Density distribution of free
fatty acid receptor 2 (FFA2)-expressing and GLP-1-producing enteroendocrine L
cells in human and rat lower intestine, and increased cell numbers after ingestion
of fructo-oligosaccharide. J Mol Histol.
11. So PW, Yu WS, Kuo YT, Wasserfall C, Goldstone AP, et al. (2007) Impact of
resistant starch on body fat patterning and central appetite regulation. PLoS
One 2: e1309.
12. Martin-Pelaez S, Gibson GR, Martin-Orue SM, Klinder A, Rastall RA, et al.
(2008) In vitro fermentation of carbohydrates by porcine faecal inocula and their
influence on Salmonella Typhimurium growth in batch culture systems. FEMS
Microbiol Ecol 66: 608–619.
13. Harmsen HJM, Elfferich P, Schut F, Welling GW (1999) A 16S rRNA-targeted
Probe for detection of lactobacilli and enterococci in faecal samples by
fluorescent in situ hybridization. Microb Ecol Health Dis 11: 3–12.
14. Langendijk PS, Schut F, Jansen GJ, Raangs GC, Kamphuis GR, et al. (1995)
Quantitative fluorescence in situ hybridization of Bifidobacterium spp. with
genus-specific 16S rRNA-targeted probes and its application in fecal samples.
Appl Environ Microbiol 61: 3069–3075.
15. Franks AH, Harmsen HJ, Raangs GC, Jansen GJ, Schut F, et al. (1998)
Variations of bacterial populations in human feces measured by fluorescent in
situ hybridization with group-specific 16S rRNA-targeted oligonucleotide
probes. Appl Environ Microbiol 64: 3336–3345.
16. Salzman NH, de JH, Paterson Y, Harmsen HJ, Welling GW, et al. (2002)
Analysis of 16S libraries of mouse gastrointestinal microflora reveals a large new
group of mouse intestinal bacteria. Microbiology 148: 3651–3660.
17. Saric J, Li JV, Wang Y, Keiser J, Bundy JG, et al. (2008) Metabolic profiling of
an Echinostoma caproni infection in the mouse for biomarker discovery. PLoS
Negl Trop Dis 2: e254.
18. Richardson AJ, Calder AG, Stewart CS, Smith A (1989) Simultaneous
determination of volatile and non-volatile acidic fermentation products of
anaerobes by capillary gas chromatography. Letters in Applied Microbiology 9:
5–8.
19. Anastasovska J, Arora T, Sanchez Canon GJ, Parkinson JR, Touhy K, et al.
(2012) Fermentable carbohydrate alters hypothalamic neuronal activity and
protects against the obesogenic environment. Obesity (Silver Spring).
20. Parkinson JR, Chaudhri OB, Bell JD (2009) Imaging appetite-regulating
pathways in the central nervous system using manganese-enhanced magnetic
resonance imaging. Neuroendocrinology 89: 121–130.
21. Patel AD, Stanley SA, Murphy KG, Frost GS, Gardiner JV, et al. (2006) Ghrelin
stimulates insulin-induced glucose uptake in adipocytes. Regul Pept 134: 17–22.
22. Frost GS, Keogh BE, Smith D, Leeds AR, Dornhorst A (1998) Reduced
adipocyte insulin sensitivity in Caucasian and Asian subjects with coronary heart
disease. Diabet Med 15: 1003–1009.
23. Frost G, Leeds A, Trew G, Margara R, Dornhorst A (1998) Insulin sensitivity in
women at risk of coronary heart disease and the effect of a low glycemic diet.
Metabolism 47: 1245–1251.
24. le Roux CW, Batterham RL, Aylwin SJ, Patterson M, Borg CM, et al. (2006)
Attenuated peptide YY release in obese subjects is associated with reduced
satiety. Endocrinology 147: 3–8.
25. Adrian TE, Ferri GL, Bacarese-Hamilton AJ, Fuessl HS, Polak JM, et al. (1985)
Human distribution and release of a putative new gut hormone, peptide YY.
Gastroenterology 89: 1070–1077.
26. Kuo YT, Herlihy AH, So PW, Bell JD (2006) Manganese-enhanced magnetic
resonance imaging (MEMRI) without compromise of the blood-brain barrier
detects hypothalamic neuronal activity in vivo. NMR Biomed 19: 1028–1034.
27. Eriksson L, Johansson E, Kettaneh-Wold N, Wold S (2002) Multi- and
Megavariate Data Analysis. Principles and Applications. Umetrics Academy.
28. Cloarec O, Dumas ME, Trygg J, Craig A, Barton RH, et al. (2005) Evaluation
of the orthogonal projection on latent structure model limitations caused by
chemical shift variability and improved visualization of biomarker changes in 1H
NMR spectroscopic metabonomic studies. Anal Chem 77: 517–526.
29. Cloarec O, Dumas ME, Craig A, Barton RH, Trygg J, et al. (2005) Statistical
total correlation spectroscopy: an exploratory approach for latent biomarker
identification from metabolic 1H NMR data sets. Anal Chem 77: 1282–1289.
30. Choi JS, Kim H, Jung MH, Hong S, Song J (2010) Consumption of barley beta-
glucan ameliorates fatty liver and insulin resistance in mice fed a high-fat diet.
Mol Nutr Food Res 54: 1004–1013.
31. Cani PD, Dewever C, Delzenne NM (2004) Inulin-type fructans modulate
gastrointestinal peptides involved in appetite regulation (glucagon-like peptide-1
and ghrelin) in rats. Br J Nutr 92: 521–526.
32. Dewulf EM, Cani PD, Neyrinck AM, Possemiers S, Van HA, et al. (2011)
Inulin-type fructans with prebiotic properties counteract GPR43 overexpression
and PPARgamma-related adipogenesis in the white adipose tissue of high-fat
diet-fed mice. J Nutr Biochem 22: 712–722.
33. Cani PD, Neyrinck AM, Fava F, Knauf C, Burcelin RG, et al. (2007) Selective
increases of bifidobacteria in gut microflora improve high-fat-diet-induced
diabetes in mice through a mechanism associated with endotoxaemia.
Diabetologia 50: 2374–2383.
34. McNeil NI (1984) The contribution of the large intestine to energy supplies in
man. Am J Clin Nutr 39: 338–342.
35. Everard A, Lazarevic V, Derrien M, Girard M, Muccioli GG, et al. (2011)
Responses of gut microbiota and glucose and lipid metabolism to prebiotics in
genetic obese and diet-induced leptin-resistant mice. Diabetes 60: 2775–2786.
36. Parkinson JR, Dhillo WS, Small CJ, Chaudhri OB, Bewick GA, et al. (2008)
PYY3-36 injection in mice produces an acute anorexigenic effect followed by a
delayed orexigenic effect not observed with other anorexigenic gut hormones.
Am J Physiol Endocrinol Metab 294: E698–E708.
37. Parkinson JR, Chaudhri OB, Kuo YT, Field BC, Herlihy AH, et al. (2009)
Differential patterns of neuronal activation in the brainstem and hypothalamus
following peripheral injection of GLP-1, oxyntomodulin and lithium chloride in
mice detected by manganese-enhanced magnetic resonance imaging (MEMRI).
Neuroimage 44: 1022–1031.
38. Wanders AJ, van den Borne JJ, de GC, Hulshof T, Jonathan MC, et al. (2011)
Effects of dietary fibre on subjective appetite, energy intake and body weight: a
systematic review of randomized controlled trials. Obes Rev 12: 724–739. 10.
39. Zhou J, Hegsted M, McCutcheon KL, Keenan MJ, Xi X, et al. (2006) Peptide
YY and proglucagon mRNA expression patterns and regulation in the gut.
Obesity (Silver Spring) 14: 683–689.
40. Zhou J, Martin RJ, Tulley RT, Raggio AM, McCutcheon KL, et al. (2008)
Dietary resistant starch upregulates total GLP-1 and PYY in a sustained day-
long manner through fermentation in rodents. Am J Physiol Endocrinol Metab
295: E1160–E1166.
Fermentable Carbohydrates and Appetite Regulation
PLOS ONE | www.plosone.org 9 August 2012 | Volume 7 | Issue 8 | e43263
41. Ge H, Li X, Weiszmann J, Wang P, Baribault H, et al. (2008) Activation of G
protein-coupled receptor 43 in adipocytes leads to inhibition of lipolysis and
suppression of plasma free fatty acids. Endocrinology 149: 4519–4526.
42. Kimura I, Inoue D, Maeda T, Hara T, Ichimura A, et al. (2011) Short-chain
fatty acids and ketones directly regulate sympathetic nervous system via G
protein-coupled receptor 41 (GPR41). Proc Natl Acad Sci U S A 108: 8030–
8035.
Fermentable Carbohydrates and Appetite Regulation
PLOS ONE | www.plosone.org 10 August 2012 | Volume 7 | Issue 8 | e43263
